当前位置: 首页 >> 检索结果
472. Five-Year Survival After Endosonography vs Mediastinoscopy for Mediastinal Nodal Staging of Lung Cancer.
作者: Jolanda C Kuijvenhoven.;Daniël A Korevaar.;Kurt G Tournoy.;Thomas L A Malfait.;Christophe Dooms.;Robert C Rintoul.;Jouke T Annema.
来源: JAMA. 2016年316卷10期1110-2页 473. Colchicine and Prevention of Cardiovascular Events.
Is continuous long-term treatment with colchicine associated with lower rates of all-cause mortality and myocardial infarction and higher rates of adverse events?
474. A Public Health Perspective on Mental and Medical Comorbidity.
Association of Mental Disorders With Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries Kate M. Scott, MA (Clin Psych), PhD; Carmen Lim, MSc; Ali Al-Hamzawi, MD; Jordi Alonso, MD, DrPH; Ronny Bruffaerts, PhD; José Miguel Caldas-de-Almeida, MD, PhD; Silvia Florescu, MD, PhD; Giovannide Girolamo, MD; Chiyi Hu, PhD; Peter de Jonge, PhD; Norito Kawakami, MD, DMSc; Maria Elena Medina-Mora, PhD; Jacek Moskalewicz, PhD; Fernando Navarro-Mateu, MD, PhD; Siobhan O’ Neill, MPsychSc, PhD; Marina Piazza, ScD, MPH; José Posada-Villa, MD; Yolanda Torres, MPH, DraHC; Ronald C. Kessler, PhD
475. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
作者: Gillian D Sanders.;Peter J Neumann.;Anirban Basu.;Dan W Brock.;David Feeny.;Murray Krahn.;Karen M Kuntz.;David O Meltzer.;Douglas K Owens.;Lisa A Prosser.;Joshua A Salomon.;Mark J Sculpher.;Thomas A Trikalinos.;Louise B Russell.;Joanna E Siegel.;Theodore G Ganiats.
来源: JAMA. 2016年316卷10期1093-103页
Since publication of the report by the Panel on Cost-Effectiveness in Health and Medicine in 1996, researchers have advanced the methods of cost-effectiveness analysis, and policy makers have experimented with its application. The need to deliver health care efficiently and the importance of using analytic techniques to understand the clinical and economic consequences of strategies to improve health have increased in recent years.
476. Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death.
作者: Ander Regueiro.;Axel Linke.;Azeem Latib.;Nikolaj Ihlemann.;Marina Urena.;Thomas Walther.;Oliver Husser.;Howard C Herrmann.;Luis Nombela-Franco.;Asim N Cheema.;Hervé Le Breton.;Stefan Stortecky.;Samir Kapadia.;Antonio L Bartorelli.;Jan Malte Sinning.;Ignacio Amat-Santos.;Antonio Munoz-Garcia.;Stamatios Lerakis.;Enrique Gutiérrez-Ibanes.;Mohamed Abdel-Wahab.;Didier Tchetche.;Luca Testa.;Helene Eltchaninoff.;Ugolino Livi.;Juan Carlos Castillo.;Hasan Jilaihawi.;John G Webb.;Marco Barbanti.;Susheel Kodali.;Fabio S de Brito.;Henrique B Ribeiro.;Antonio Miceli.;Claudia Fiorina.;Guglielmo Mario Actis Dato.;Francesco Rosato.;Vicenç Serra.;Jean-Bernard Masson.;Harindra C Wijeysundera.;Jose A Mangione.;Maria-Cristina Ferreira.;Valter C Lima.;Luiz A Carvalho.;Alexandre Abizaid.;Marcos A Marino.;Vinicius Esteves.;Julio C M Andrea.;Francesco Giannini.;David Messika-Zeitoun.;Dominique Himbert.;Won-Keun Kim.;Costanza Pellegrini.;Vincent Auffret.;Fabian Nietlispach.;Thomas Pilgrim.;Eric Durand.;John Lisko.;Raj R Makkar.;Pedro A Lemos.;Martin B Leon.;Rishi Puri.;Alberto San Roman.;Alec Vahanian.;Lars Søndergaard.;Norman Mangner.;Josep Rodés-Cabau.
来源: JAMA. 2016年316卷10期1083-92页
Limited data exist on clinical characteristics and outcomes of patients who had infective endocarditis after undergoing transcatheter aortic valve replacement (TAVR).
477. Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes and Association With Reduced Cost and Improved Quality.
作者: Vivian S Lee.;Kensaku Kawamoto.;Rachel Hess.;Charlton Park.;Jeffrey Young.;Cheri Hunter.;Steven Johnson.;Sandi Gulbransen.;Christopher E Pelt.;Devin J Horton.;Kencee K Graves.;Tom H Greene.;Yoshimi Anzai.;Robert C Pendleton.
来源: JAMA. 2016年316卷10期1061-72页
Transformation of US health care from volume to value requires meaningful quantification of costs and outcomes at the level of individual patients.
|